Strategies to promote access to medications during the COVID-19 pandemic

被引:0
作者
Bell, J. Simon [1 ]
Reynolds, Lorenna [1 ]
Freeman, Christopher [2 ,3 ]
Jackson, John K. [1 ]
机构
[1] Monash Univ, Ctr Med Use & Safety, Fac Pharm & Pharmaceut Sci, Clayton, Vic, Australia
[2] Univ Queensland, Ctr Optimising Pharm Practice Based Excellence Re, Sch Pharm, Brisbane, Qld, Australia
[3] Pharmaceut Soc Australia, Deakin, ACT, Australia
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background During the COVID-19 pandemic, vulnerable and older people with chronic and complex conditions have self-isolated in their homes, potentially limiting opportunities for consultations to have medications prescribed and dispensed. Objective The aim of this article is to describe initiatives to ensure ongoing access to medications during the COVID-19 pandemic. Discussion Cooperation between wholesalers and purchase limits in pharmacies have helped to ensure supply of essential medications. Therapeutic substitution by pharmacists is permitted for specific products authorised by the Therapeutic Goods Administration. Prescribers are permitted to issue digital image prescriptions, and implementation of electronic prescribing has been fast-tracked. Expanded continued dispensing arrangements introduced during the bushfire crises have been temporarily extended. Pharmacists are permitted to provide medication management reviews via telehealth. A Home Medicines Service has been introduced to facilitate delivery of medications to people who are vulnerable or elderly. Anticipatory prescribing and medication imprest systems are valuable for access to end-of-life medications within residential aged care.
引用
收藏
页码:530 / 532
页数:3
相关论文
共 18 条
  • [1] American Geriatrics Society, 2020, J AM GERIATR SOC, V68, P908, DOI [10.1111/jgs.16477, DOI 10.1111/JGS.16477]
  • [2] Australian Competition and Consumer Commission, 2020, MED WHOL COOP ACC PH
  • [3] Australian Digital Health Agency, 2020, EL PRESCR PRESCR
  • [4] Bell JS, 2020, AUST J GEN PRACT, V49, DOI 10.31128/AJGP-COVID-06
  • [5] Centers for Disease Control and Prevention, 2019, COR DIS 2019 COVID 1
  • [6] Department of Health and Ageing, 2012, GUID PRINC MED MAN R
  • [7] A scoping review of the use and impact of telehealth medication reviews
    Hanjani, Leila Shafiee
    Caffery, Liam J.
    Freeman, Christopher R.
    Peeters, Geeske
    Peel, Nancye M.
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (08) : 1140 - 1153
  • [8] International Pharmaceutical Federation, 2013, REP INT SUMM MED SHO
  • [9] Estimation of Potential Savings Through Therapeutic Substitution
    Johansen, Michael E.
    Richardson, Caroline
    [J]. JAMA INTERNAL MEDICINE, 2016, 176 (06) : 769 - 775
  • [10] New regulatory strategies to manage medicines shortages in Europe
    Musazzi, Umberto M.
    Di Giorgio, Domenico
    Minghetti, Paola
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 579